By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NicOx SA 

1900 Route des CrĂȘtes, BP 313

Sophia-Antipolis  Cedex  06906  France
Phone: 33-0-4-92387020 Fax: 33-0-4-92387030


Drug Discovery


Merck & Co.  Nitric oxide-donating compounds

Company News
NicOx SA (COX.PA): Report On The Termination Of The Liquidity Agreement With Gilbert Dupont 6/1/2017 12:48:24 PM
NicOx SA (COX.PA) Receives FDA Approval Of ZERVIATE1 (Cetirizine Ophthalmic Solution) 0.24% 5/31/2017 9:05:29 AM
Ms. Lauren P. Silvernail Appointed To NicOx SA (COX.PA) Board Of Directors 5/17/2017 11:10:11 AM
NicOx SA (COX.PA) First Quarter 2017 Business Update And Cash Position 4/27/2017 11:04:53 AM
NicOx SA (COX.PA) Announces PDUFA Date For ZERVIATE NDA 4/11/2017 10:23:47 AM
NicOx SA (COX.PA): Business Update And 2016 Financial Results 3/31/2017 10:42:52 AM
Bausch & Lomb And NicOx SA (COX.PA) Announce PDUFA Date For Novel Glaucoma Candidate Latanoprostene Bunod 3/21/2017 6:33:25 AM
NicOx SA (COX.PA) Resubmits AC-170 (ZERVIATE) NDA To The FDA 3/9/2017 10:38:41 AM
Bausch & Lomb And NicOx SA (COX.PA) Resubmit US New Drug Application For Novel Glaucoma Candidate Latanoprostene Bunod 2/27/2017 6:24:29 AM
NicOx SA (COX.PA) Announces The Presentation Of NCX 667 Scientific Data At AOPT 2017 2/21/2017 11:01:34 AM